Skip to main content

Security report for akdae.de

Arzneimittelkommission der deutschen Ärzteschaft · Healthcare · Germany

Medium risk. 3 critical or high findings in Security headers and SSL/TLS.

Security score

75/100

Risk levelMedium

0–100, higher is better. How it is calculated

The Arzneimittelkommission der deutschen Ärzteschaft (AkdÄ) is a scientific advisory committee affiliated with the German Federal Medical Association (Bundesärztekammer). It serves as an authoritative body providing drug safety information, pharmaceutical therapy guidelines, and regulatory statements to healthcare professionals in Germany. The website offers comprehensive resources including news updates, educational materials, and official publications, targeting medical practitioners and regulatory stakeholders. The business model is non-profit and focused on public health and safety. Technically, the website is built on the TYPO3 CMS platform, leveraging modern technologies such as Bootstrap 5 and FontAwesome for responsive and accessible design. Hosting is provided by SchlundTech, a reputable German hosting provider. The site demonstrates good digital maturity with GDPR-compliant cookie consent managed by Cookiebot and privacy-respecting analytics via Matomo. Performance and SEO are moderate to good, with clear navigation and mobile optimization. From a security perspective, the site enforces HTTPS and employs cookie consent mechanisms, but lacks explicit security headers and published incident response or vulnerability disclosure policies. No critical vulnerabilities or suspicious activities were detected. Privacy compliance is strong, with a comprehensive privacy policy and cookie management. Overall, the website is a trustworthy, professional resource with high content quality and business credibility. Strategic recommendations include enhancing security headers, publishing a security.txt file, and providing explicit incident response contacts to further strengthen security posture and transparency.

Scanned

NIS2 and GDPR posture

GDPR outside view
95/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching akdae.de

This scan found 22 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
72
Security headers
40
Email security
75
DNS health
65
Network security
100
GDPR outside view
95
Average
75

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention akdae.de, from OffSeq Breach.

No leaked records found

Breach holds no records for akdae.de right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

AkdÄ holds a strong market position as a government-affiliated healthcare advisory entity in Germany. Its competitive advantage lies in its official status and authoritative content on drug safety and pharmaceutical therapy. The business operates on a non-profit model, focusing on knowledge dissemination rather than commercial revenue. Target customers are healthcare professionals and regulatory bodies. The partnership ecosystem includes the Bundesärztekammer and other German health authorities. Growth indicators include regular publication updates and active engagement in drug safety communications. The organization's operations emphasize scientific rigor and regulatory compliance.

Security posture

The website exhibits a mature security posture with enforced HTTPS and GDPR-compliant cookie consent. Use of Matomo analytics indicates a privacy-conscious approach. However, the absence of security headers such as Content-Security-Policy and lack of published incident response or vulnerability disclosure policies represent gaps. No exposed sensitive data or vulnerable libraries were detected. The site would benefit from formalizing security policies and providing clear channels for security incident reporting to enhance readiness and trust.

Recommendations

  1. Implement comprehensive HTTP security headers including Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options.
  2. Publish a security.txt file to facilitate vulnerability disclosure and improve transparency.
  3. Provide explicit incident response contact information on the website.
  4. Regularly audit and update third-party scripts and libraries to mitigate potential vulnerabilities.
  5. Enhance user trust by including terms of service and more detailed business contact information.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Arzneimittelkommission der deutschen Ärzteschaft
Description
Wissenschaftlicher Fachausschuss der Bundesärztekammer, providing information and resources related to drug safety, pharmaceutical therapy, and regulatory statements in Germany.
Key services
Drug safety notifications, Pharmaceutical therapy guidelines, Regulatory statements and assessments, Educational materials and newsletters
Content quality
excellent
Branding
consistent

Technology

Stack
TYPO3 CMS, Bootstrap 5, FontAwesome, Cookiebot, Matomo Analytics
Frameworks
TYPO3 CMS
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent with opt-in/out
  • No exposed sensitive data in HTML
  • Use of Matomo for privacy-respecting analytics

Analytics and tracking

Services
Matomo
Tracking level
minimal
Privacy practices
excellent

Advertising

Tracking pixels
Matomo
Marketing tools
Cookiebot
Transparency
excellent

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is a professional, authoritative source for drug safety and pharmaceutical information in Germany.
  2. Uses modern CMS TYPO3 with responsive design and accessibility considerations.
  3. Strong privacy compliance with GDPR cookie consent and detailed privacy policy.
  4. No signs of malicious or suspicious activity.
  5. No direct contact emails or phone numbers found in HTML; contact via dedicated contact page.
  6. No terms of service page detected.
  7. No explicit security or incident response policies published.
  8. No vulnerability disclosure or security.txt found.
Technical notes

Notes

The website is built on TYPO3 CMS, a robust and widely used content management system, ensuring scalability and maintainability. The use of Bootstrap 5 and FontAwesome supports responsive and visually consistent design. Hosting by SchlundTech provides reliable infrastructure. Cookiebot integration ensures compliance with cookie regulations. Matomo analytics is used for privacy-respecting user tracking. Performance is moderate, with potential for optimization. Accessibility features and SEO best practices are well implemented. Technical risks are minimal but could be further reduced by adding security headers and formalizing security policies.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with akdae.de. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review akdae.de.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.